losartan and Urinary Bladder, Neurogenic studies

Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position

Urinary Bladder, Neurogenic: Dysfunction of the URINARY BLADDER due to disease of the central or peripheral nervous system pathways involved in the control of URINATION. This is often associated with SPINAL CORD DISEASES, but may also be caused by BRAIN DISEASES or PERIPHERAL NERVE DISEASES.

Research Excerpts

Excerpt	Relevance	Reference
"To investigate the effect of losartan on preventing bladder fibrosis and protecting renal function in rats with neurogenic paralysis bladder (NPB)."	8.02	Losartan prevents bladder fibrosis and protects renal function in rat with neurogenic paralysis bladder. ( Bauer, SB; Chen, Y; He, YL; Ji, FP; Liu, EP; Ma, Y; Pu, QS; Wang, QW; Wang, Y; Wen, JG; Wen, YB; Xing, D; Yang, XH; Zhai, RQ, 2021)
"To investigate the effect of losartan on preventing bladder fibrosis and protecting renal function in rats with neurogenic paralysis bladder (NPB)."	4.02	Losartan prevents bladder fibrosis and protects renal function in rat with neurogenic paralysis bladder. ( Bauer, SB; Chen, Y; He, YL; Ji, FP; Liu, EP; Ma, Y; Pu, QS; Wang, QW; Wang, Y; Wen, JG; Wen, YB; Xing, D; Yang, XH; Zhai, RQ, 2021)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

losartan and Urinary Bladder, Neurogenic

Research Excerpts

Research

Studies (1)

Authors

Other Studies

Authors	Studies
He, YL	1
Wen, JG	1
Pu, QS	1
Wen, YB	1
Zhai, RQ	1
Chen, Y	1
Ma, Y	1
Liu, EP	1
Xing, D	1
Ji, FP	1
Yang, XH	1
Wang, QW	1
Wang, Y	1
Bauer, SB	1